Drug
Carbidopa Levodopa
Carbidopa Levodopa is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
3
75%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 43 (75.0%)
Trials by Status
withdrawn125%
completed250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
Dopaminergic Therapy for Anhedonia - 2
NCT06075771
completedphase_4
DTA (Dopaminergic Therapy for Anhedonia) Study
NCT04723147
withdrawnphase_4
Research on Translational Outcomes of Alcohol (Project RETRO)
NCT04742348
completedphase_1
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
NCT03496870
Clinical Trials (4)
Showing 4 of 4 trials
NCT06075771Phase 4
Dopaminergic Therapy for Anhedonia - 2
NCT04723147Phase 4
DTA (Dopaminergic Therapy for Anhedonia) Study
NCT04742348Phase 4
Research on Translational Outcomes of Alcohol (Project RETRO)
NCT03496870Phase 1
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4